About
Technology
Issues
FAQ
Links
Official Page
First‐line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation
in vitro
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.